Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers

Berlau, 2009, APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old, Neurology, 72, 829, 10.1212/01.wnl.0000343853.00346.a4 Bookheimer, 2000, Patterns of brain activation in people at risk for Alzheimer's disease, N Engl J Med, 343, 450, 10.1056/NEJM200008173430701 Brown, 2011, Brain network local interconnectivity loss in aging APOE-4 allele carriers, Proc Natl Acad Sci U S A, 108, 20760, 10.1073/pnas.1109038108 Bunce, 2012, APOE genotype and entorhinal cortex volume in non-demented community-dwelling adults in midlife and early old age, J Alzheimers Dis, 30, 935, 10.3233/JAD-2012-112126 Burggren, 2008, Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers, Neuroimage, 41, 1177, 10.1016/j.neuroimage.2008.03.039 Chen, 2012, Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ɛ4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares, Neuroimage, 60, 2316, 10.1016/j.neuroimage.2012.02.005 Chen, 2007, Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates, Am J Psychiatry, 164, 916, 10.1176/ajp.2007.164.6.916 Chiang, 2010, Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects, Neurology, 75, 1976, 10.1212/WNL.0b013e3181ffe4d1 Chiang, 2011, Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1year in mild cognitive impairment, Alzheimers Dement, 7, 514, 10.1016/j.jalz.2010.12.010 Cohen, 2001, Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women, Neurology, 57, 2223, 10.1212/WNL.57.12.2223 Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261, 921, 10.1126/science.8346443 Dennis, 2010, Temporal lobe functional activity and connectivity in young adult APOE varepsilon4 carriers, Alzheimers Dement, 6, 303, 10.1016/j.jalz.2009.07.003 Desikan, 2013, Apolipoprotein E epsilon4 does not modulate amyloid-β-associated neurodegeneration in preclinical Alzheimer disease, Am J Neuroradiol, 34, 505, 10.3174/ajnr.A3267 Donix, 2010, Family history of Alzheimer's disease and hippocampal structure in healthy people, Am J Psychiatry, 167, 1399, 10.1176/appi.ajp.2010.09111575 Donix, 2010, Longitudinal changes in medial temporal cortical thickness in normal subjects with the APOE-4 polymorphism, Neuroimage, 53, 37, 10.1016/j.neuroimage.2010.06.009 Donix, 2012, Family history and APOE-4 genetic risk in Alzheimer's disease, Neuropsychol Rev, 22, 298, 10.1007/s11065-012-9193-2 Dubois, 2010, Revising the definition of Alzheimer's disease: a new lexicon, Lancet Neurol, 9, 1118, 10.1016/S1474-4422(10)70223-4 Espeseth, 2008, Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E epsilon 4, Neurobiol Aging, 29, 329, 10.1016/j.neurobiolaging.2006.10.030 Fan, 2010, Cortical thickness is associated with different apolipoprotein E genotypes in healthy elderly adults, Neurosci Lett, 479, 332, 10.1016/j.neulet.2010.05.092 Farrer, 1997, Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta-analysis consortium, J Am Med Assoc, 278, 1349, 10.1001/jama.1997.03550160069041 Fennema-Notestine, 2011, Presence of ApoE ɛ4 allele associated with thinner frontal cortex in middle age, J Alzheimers Dis, 26, 49, 10.3233/JAD-2011-0002 Filippini, 2011, Differential effects of the APOE genotype on brain function across the lifespan, Neuroimage, 54, 602, 10.1016/j.neuroimage.2010.08.009 Filippini, 2009, Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele, Proc Natl Acad Sci U S A, 106, 7209, 10.1073/pnas.0811879106 Fleisher, 2009, Cerebral perfusion and oxygenation differences in Alzheimer's disease risk, Neurobiol Aging, 30, 1737, 10.1016/j.neurobiolaging.2008.01.012 Fleisher, 2013, Apolipoprotein E ɛ4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease, Neurobiol Aging, 34, 1, 10.1016/j.neurobiolaging.2012.04.017 Gallagher, 2011, Episodic memory on the path to Alzheimer's disease, Curr Opin Neurobiol, 21, 929, 10.1016/j.conb.2011.10.021 Genin, 2011, APOE and Alzheimer disease: a major gene with semi-dominant inheritance, Mol Psychiatry, 16, 903, 10.1038/mp.2011.52 Han, 2007, Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response, Neurobiol Aging, 28, 238, 10.1016/j.neurobiolaging.2005.12.013 Den Heijer, 2002, Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes, Neurology, 59, 746, 10.1212/WNL.59.5.746 Hinrichs, 2010, Cortical binding of pittsburgh compound B, an endophenotype for genetic studies of Alzheimer's disease, Biol Psychiatry, 67, 581, 10.1016/j.biopsych.2009.09.012 Honea, 2011, Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease, Neurology, 76, 822, 10.1212/WNL.0b013e31820e7b74 Honea, 2010, Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease, Neurology, 74, 113, 10.1212/WNL.0b013e3181c918cb Honea, 2009, Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study, J Alzheimers Dis, 18, 553, 10.3233/JAD-2009-1163 Hostage, 2013, Alzheimer's disease neuroimaging initiative. Dissecting the gene dose-effects of the APOE ɛ4 and ɛ2 alleles on hippocampal volumes in aging and Alzheimer's disease, PLoS One, 8, e54483, 10.1371/journal.pone.0054483 Hua, 2010, Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans, Neurobiol Aging, 31, 1463, 10.1016/j.neurobiolaging.2010.04.033 Hua, 2008, Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects, Neuroimage, 43, 458, 10.1016/j.neuroimage.2008.07.013 Huang, 2010, Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease, Trends Mol Med, 16, 287, 10.1016/j.molmed.2010.04.004 Huang, 2012, Alzheimer mechanisms and therapeutic strategies, Cell, 148, 1204, 10.1016/j.cell.2012.02.040 Jack, 1998, Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease, Ann Neurol, 43, 303, 10.1002/ana.410430307 Jagust, 2012, Apolipoprotein E, not fibrillar β-amyloid, reduces cerebral glucose metabolism in normal aging, J Neurosci., 32, 18227, 10.1523/JNEUROSCI.3266-12.2012 Kantarci, 2012, APOE modifies the association between Aβ load and cognition in cognitively normal older adults, Neurology, 78, 232, 10.1212/WNL.0b013e31824365ab Kim, 2009, The role of apolipoprotein E in Alzheimer's disease, Neuron, 63, 287, 10.1016/j.neuron.2009.06.026 Knickmeyer, 2013, Common variants in psychiatric risk genes predict brain structure at birth, Cereb Cortex Kukolja, 2010, Medial temporal lobe dysfunction during encoding and retrieval of episodic memory in non-demented APOE epsilon4 carriers, Neuroscience, 168, 487, 10.1016/j.neuroscience.2010.03.044 Lemaître, 2005, No epsilon4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects, Neuroimage, 24, 1205, 10.1016/j.neuroimage.2004.10.016 Lind, 2006, Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory, Neurosci Lett, 396, 23, 10.1016/j.neulet.2005.11.070 Liu, 2010, Effect of APOE ɛ4 allele on cortical thicknesses and volumes: the AddNeuroMed study, J Alzheimers Dis, 21, 947, 10.3233/JAD-2010-100201 Liu, 2010, APOE ɛ2 allele is associated with larger regional cortical thicknesses and volumes, Dement Geriatr Cogn Disord, 30, 229, 10.1159/000320136 Liu, 2013, Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy, Nat Rev Neurol, 9, 106, 10.1038/nrneurol.2012.263 Lu, 2011, Apolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: a tensor-based morphometry study, J Alzheimers Dis, 23, 433, 10.3233/JAD-2010-101398 Mathis, 2013, In vivo assessment of amyloid-β deposition in nondemented very elderly subjects, Ann Neurol, 73, 751, 10.1002/ana.23797 Mielke, 2012, Indicators of amyloid burden in a population-based study of cognitively normal elderly, Neurology, 79, 1570, 10.1212/WNL.0b013e31826e2696 Morra, 2009, Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls, Neuroimage, 45, S3, 10.1016/j.neuroimage.2008.10.043 Morris, 2010, APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging, Ann Neurol, 67, 122, 10.1002/ana.21843 Mosconi, 2007, Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism, Proc Natl Acad Sci U S A, 104, 19067, 10.1073/pnas.0705036104 Mosconi, 2009, Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease, Neurology, 72, 513, 10.1212/01.wnl.0000333247.51383.43 Mueller, 2008, Selective effect of Apo e4 on CA3 and dentate in normal aging and Alzheimer's disease using high resolution MRI at 4T, Neuroimage, 42, 42, 10.1016/j.neuroimage.2008.04.174 Mueller, 2009, Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields, Hippocampus, 19, 558, 10.1002/hipo.20614 Murphy, 2013, Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth, Neuroimage, 78, 474, 10.1016/j.neuroimage.2013.04.048 O’Dwyer, 2012, Reduced hippocampal volume in healthy young ApoE4 carriers: an MRI study, PLoS One, 7, e48895, 10.1371/journal.pone.0048895 Plassman, 1997, Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition, Neurology, 48, 985, 10.1212/WNL.48.4.985 Protas, 2013, Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease, JAMA Neurol, 70, 320, 10.1001/2013.jamaneurol.286 Reiman, 1996, Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E, N Engl J Med, 334, 752, 10.1056/NEJM199603213341202 Reiman, 2004, Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia, Proc Natl Acad Sci U S A, 101, 284, 10.1073/pnas.2635903100 Reiman, 2005, Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia, Proc Natl Acad Sci U S A, 101, 284, 10.1073/pnas.2635903100 Reiman, 2005, Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism, Proc Natl Acad Sci U S A, 102, 8299, 10.1073/pnas.0500579102 Reiman, 2009, Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease, Proc Natl Acad Sci U S A, 106, 6820, 10.1073/pnas.0900345106 Reiman, 1998, Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease, Ann Neurol, 44, 288, 10.1002/ana.410440226 Risacher, 2010, Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort, Neurobiol Aging, 31, 1401, 10.1016/j.neurobiolaging.2010.04.029 Rodrigue, 2012, β-Amyloid burden in healthy aging: regional distribution and cognitive consequences, Neurology, 78, 387, 10.1212/WNL.0b013e318245d295 Rowe, 2010, Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging, Neurobiol Aging, 31, 1275, 10.1016/j.neurobiolaging.2010.04.007 Saunders, 1993, Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases, Lancet, 342, 710, 10.1016/0140-6736(93)91709-U Schipper, 2011, Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment, Neurobiol Aging, 32, 778, 10.1016/j.neurobiolaging.2009.04.021 Schmidt, 1996, Apolipoprotein E e4 allele in the normal elderly: neuropsychologic and brain MRI correlates, Clin Genet, 50, 293, 10.1111/j.1399-0004.1996.tb02377.x Schuff, 2009, MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers, Brain J Neurol, 132, 1067 Shaw, 2007, Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study, Lancet Neurol, 6, 494, 10.1016/S1474-4422(07)70106-0 Sheline, 2010, APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Aβ42, J Neurosci, 30, 17035, 10.1523/JNEUROSCI.3987-10.2010 Small, 1995, Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease, J Am Med Assoc, 273, 942, 10.1001/jama.1995.03520360056039 Small, 2009, Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia, Arch Gen Psychiatry, 66, 81, 10.1001/archgenpsychiatry.2008.516 Soininen, 1995, Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon 4 allele, Neurology, 45, 391, 10.1212/WNL.45.2.391 Sperling, 2011, Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement, 7, 280, 10.1016/j.jalz.2011.03.003 Suthana, 2010, Reduced hippocampal CA2, CA3, and dentate gyrus activity in asymptomatic people at genetic risk for Alzheimer's disease, Neuroimage, 53, 1077, 10.1016/j.neuroimage.2009.12.014 Thambisetty, 2010, APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging, Arch Neurol, 67, 93, 10.1001/archneurol.2009.913 Tohgi, 1997, Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon4 allele, Neurosci Lett, 236, 21, 10.1016/S0304-3940(97)00743-X Trachtenberg, 2012, The effects of APOE on brain activity do not simply reflect the risk of Alzheimer's disease, Neurobiol Aging, 33, e1, 10.1016/j.neurobiolaging.2010.11.011 Tuminello, 2011, The apolipoprotein e antagonistic pleiotropy hypothesis: review and recommendations, Int J Alzheimers Dis, 2011, 726197 Vemuri, 2010, Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease, Ann Neurol, 67, 308 Villemagne, 2011, Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease, Ann Neurol, 69, 181, 10.1002/ana.22248 Vlassenko, 2011, Amyloid-beta plaque growth in cognitively normal adults: longitudinal [11C]Pittsburgh compound B data, Ann Neurol, 70, 857, 10.1002/ana.22608 Westlye, 2011, Increased hippocampal default mode synchronization during rest in middle-aged and elderly APOE ɛ4 carriers: relationships with memory performance, J Neurosci, 31, 7775, 10.1523/JNEUROSCI.1230-11.2011 Wishart, 2006, Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele, Neurology, 67, 1221, 10.1212/01.wnl.0000238079.00472.3a